RenovoRx (NASDAQ:RNXT) Stock Price Down 7.6%
RenovoRx (NASDAQ:RNXT) Stock Price Down 7.6%
RenovoRx, Inc. (NASDAQ:RNXT – Get Rating)'s stock price traded down 7.6% during trading on Wednesday . The stock traded as low as $3.54 and last traded at $3.65. 354,715 shares traded hands during trading, an increase of 346% from the average session volume of 79,574 shares. The stock had previously closed at $3.95.
RenoorX 公司 (納斯達克:RNXT — 獲得評級) 的股票價格在星期三交易期間下跌 7.6%。該股價低至 3.54 美元,最後成交價為 3.65 美元。354,715 股在交易過程中交易手數,較 79,574 股的平均交易量上升 346%。該股票之前已收盤 3.95 美元。
RenovoRx Stock Performance
雷諾科技股票表現
The company has a market cap of $33.11 million, a price-to-earnings ratio of -3.72 and a beta of 0.25. The stock's fifty day moving average is $2.23 and its two-hundred day moving average is $2.13.
該公司的市值為 33.11 萬美元,價格與收益比為 -3.72,測試版為 0.25。該股票的五十天移動平均線為 2.23 美元,其 200 日移動平均線為 2.13 美元。
RenovoRx (NASDAQ:RNXT – Get Rating) last issued its quarterly earnings data on Monday, November 14th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. On average, equities research analysts expect that RenovoRx, Inc. will post -1.11 EPS for the current year.
雷諾沃克 (NASDAQ: RNXT — 獲得評分) 最近一次發佈其季度盈利數據,日期為 11 月 14 日,星期一。該公司報告了本季每股盈利(0.24 美元),超過 0.27 美元的共識估計(0.27 美元)0.03 美元。平均而言,股票研究分析師預計 RenoorX 公司將在本年度每股盈利 -1.11。
Hedge Funds Weigh In On RenovoRx
對沖基金權衡雷諾
RenovoRx Company Profile
瑞諾公司簡介
(Get Rating)
(取得評分)
RenovoRx, Inc, a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer.
RenoorX, Inc 是一家臨床階段生物製藥公司,專注於開發用於治療實體瘤的療法。其主要候選產品是 ReNovogem,這是一種由動脈內吉西他濱和 ReNovoCath 組成的藥物和器件組合,該藥物和器件組合在局部晚期胰腺癌的 III 期臨床試驗中。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on RenovoRx (RNXT)
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- 獲取有關雷諾沃克斯(RNXT)的研究報告的免費副本
- 寶潔公司的收益:值得參加的賭博
- 股票幻燈片,經濟報告描繪經濟陰沉的圖片
- NU 控股股票與沃倫·巴菲特有什麼關係?
- J.B. 亨特得到一個單位, 物流公司成為焦點
- 英特爾股票是否瀕臨爆發?
Receive News & Ratings for RenovoRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenovoRx and related companies with MarketBeat.com's FREE daily email newsletter.
接收 RenoorX 每日最新消息和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 RenoorX 及相關公司的最新新聞和分析師評級的簡要每日摘要。